We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 154.21 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2020 to Jan 2025
TIDM0Y7T TIDMIRSH TIDMBARC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC. Company dealt in ALLERGAN PLC Class of relevant security to which the dealings being ORD disclosed relate (Note 2) Date of dealing 11 May 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Hot Features
Premium
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
90,736 0.03% 7 0.00%
(2) Derivatives (other than options):
659,745 0.20% 2,030,031 0.62%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
750,481 0.23% 2,030,038 0.62%
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit Purchase 22,362 193.0200 USD Sale 551,088 193.0200 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit e.g. CFD (Note 6) securities (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type Expiry Option
Name
purchasing, of price date money
selling, securities paid/
varying etc to which received
option
relates
Call Purchasing 42,500 165 USD American 21 Jan 26.5000
Option 2022 USD
Call Purchasing 1,100 200 USD American 21 Aug 2.2000 USD
Option 2020
Call Purchasing 1,500 220 USD American 21 Aug 0.2100 USD
Option 2020
Call Purchasing 1,400 230 USD American 19 Jun 0.0800 USD
Option 2020
Call Purchasing 7,200 260 USD American 15 Jan 0.4000 USD
Option 2021
Call Selling 600 150 USD American 15 Jan 40.9000
Option 2021 USD
Call Selling 3,400 160 USD American 15 Jan 26.3000
Option 2021 USD
Call Selling 1,700 170 USD American 15 May 22.6000
Option 2020 USD
Call Selling 9,500 170 USD American 19 Jun 20.6500
Option 2020 USD
Call Selling 6,400 175 USD American 15 May 19.5300
Option 2020 USD
Call Selling 600 175 USD American 15 Jan 18.5000
Option 2021 USD
Call Selling 32,500 175 USD American 21 Jan 18.0000
Option 2022 USD
Call Selling 6,400 185 USD American 15 Jan 11.0000
Option 2021 USD
Call Selling 1,200 190 USD American 15 May 4.0000 USD
Option 2020
Call Selling 4,400 190 USD American 15 Jan 9.4000 USD
Option 2021
Call Selling 9,100 195 USD American 15 Jan 5.4500 USD
Option 2021
Put Purchasing 33,200 140 USD American 19 Jun 0.0100 USD
Option 2020
Put Purchasing 8,200 150 USD American 15 May 0.7700 USD
Option 2020
Put Purchasing 600 150 USD American 19 Jun 0.2000 USD
Option 2020
Put Purchasing 100 165 USD American 15 May 0.0500 USD
Option 2020
Put Purchasing 2,700 180 USD American 15 May 0.1500 USD
Option 2020
Put Purchasing 200 190 USD American 21 Aug 4.2000 USD
Option 2020
Put Purchasing 4,500 195 USD American 21 Aug 4.2500 USD
Option 2020
Put Purchasing 3,700 215 USD American 15 Jan 23.5000
Option 2021 USD
Put Selling 1,200 65 USD American 15 Jan 0.0500 USD
Option 2021
Put Selling 4,500 70 USD American 15 Jan 0.4700 USD
Option 2021
Put Selling 16,500 115 USD American 15 Jan 0.4600 USD
Option 2021
Put Selling 29,400 150 USD American 15 Jan 0.3500 USD
Option 2021
Put Selling 2,400 160 USD American 15 Jan 2.8000 USD
Option 2021
Put Selling 6,300 170 USD American 19 Jun 0.0900 USD
Option 2020
Put Selling 5,100 170 USD American 15 Jan 1.9500 USD
Option 2021
Put Selling 900 175 USD American 21 Aug 0.7500 USD
Option 2020
Put Selling 7,200 180 USD American 15 Jan 4.9000 USD
Option 2021
Put Selling 600 185 USD American 15 May 0.0300 USD
Option 2020
Put Selling 900 185 USD American 15 Jan 5.0000 USD
Option 2021
Put Selling 1,000 195 USD American 15 May 2.9300 USD
Option 2020
Put Selling 100 195 USD American 19 Jun 2.1000 USD
Option 2020
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5) e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 12May 2020 Contact name Large Holdings Regulatory Operations Telephone number 020 3134 7213 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10)
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
UNKNOWN 0
UNKNOWN 0
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005409/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC
Copyright Business Wire 2020
(END) Dow Jones Newswires
May 12, 2020 05:43 ET (09:43 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
